1. Home
  2. CRSR vs CRVS Comparison

CRSR vs CRVS Comparison

Compare CRSR & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

BUY

Current Price

$13.39

Market Cap

1.2B

Sector

Technology

ML Signal

BUY

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$12.75

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSR
CRVS
Founded
1994
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
CRSR
CRVS
Price
$13.39
$12.75
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$8.50
$30.17
AVG Volume (30 Days)
1.1M
809.3K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
87.37
48.04
EPS
0.17
N/A
Revenue
$1,472,480,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.90
N/A
P/E Ratio
$79.53
N/A
Revenue Growth
11.86
N/A
52 Week Low
$4.48
$6.12
52 Week High
$14.98
$26.95

Technical Indicators

Market Signals
Indicator
CRSR
CRVS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CRSR
CRVS

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the United States (U.S.), Americas (excluding U.S.) , Europe and the Middle East, and the Asia Pacific, of which maximum revenue is generated from United States (U.S.).

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: